Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 0, Open Label, Non-randomized, Multi-center, Exploratory and Safety Study of [F-18]W372

NCT00954369 is registered in ClinicalTrials.gov with Siemens Molecular Imaging as lead sponsor.

NCT NCT00954369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00954369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 0, Open Label, Non-randomized, Multi-center, Exploratory and Safety Study of [F-18]W372
Lead sponsor
Siemens Molecular Imaging
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2009
Completion date
February 28, 2010
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease